SCHEMBL4253876

SCHEMBL4253876

Nc1nc(C(=O)C(=O)O)c(Br)s1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
COPS5 Q92905 7/20 0.40
ALDH1A1 P00352 4/20 0.35
CYP1A2 P05177 2/20 0.35
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
ALOX12 P18054 1/20 0.34
KMT2A Q03164 1/20 0.34
FBP1 P09467 1/20 0.33
PKM P14618 2/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
NSD1 Q96L73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873247 0.83 COPS5 (0.49) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL26851680 0.79 COPS5 (0.38) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL4257076 0.76 ALDH1A1 (0.36) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL13609507 0.74 ALDH1A1 (0.53) COPS5ALDH1A1CYP1A2HSD17B10SMN1; SMN2
SCHEMBL1549089 0.73 ALDH1A1 (0.54) ALDH1A1CYP1A2KDM4EHSD17B10SMN1; SMN2
SCHEMBL11375087 0.73 ALDH1A1 (0.38) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL1758948 0.72 ALDH1A1 (0.44) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL7763021 0.71 ALDH1A1 (0.33) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL7763024 0.71 ALDH1A1 (0.33) COPS5ALDH1A1CYP1A2KDM4EHSD17B10
SCHEMBL8818161 0.70 ALDH1A1 (0.41) COPS5ALDH1A1CYP1A2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281142-A1 THIAZOLE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-12 US disclosed
EP-1921074-A1 THIAZOLE DERIVATIVE Astellas Pharma Inc. (JP) 2008-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281142-A1 THIAZOLE DERIVATIVE GK, GCKR, AK2 COPS5 4318/4885ALDH1A1 1817/4885CYP1A2 2841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.